BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22674990)

  • 1. A vesiculovirus showing a steepened transcription gradient and dominant trans-repression of virus transcription.
    Hodges EN; Heinrich BS; Connor JH
    J Virol; 2012 Aug; 86(16):8884-9. PubMed ID: 22674990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication and transcription of viral RNAs by recombinant L proteins of New Jersey serotype of vesicular stomatitis virus.
    Kim GN; Choi WY; Park M; Kang CY
    Virus Res; 2002 Dec; 90(1-2):347-64. PubMed ID: 12457988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligomerization of the Vesicular Stomatitis Virus Phosphoprotein Is Dispensable for mRNA Synthesis but Facilitates RNA Replication.
    Bloyet LM; Morin B; Brusic V; Gardner E; Ross RA; Vadakkan T; Kirchhausen T; Whelan SPJ
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection for gene junction sequences important for VSV transcription.
    Hinzman EE; Barr JN; Wertz GW
    Virology; 2008 Oct; 380(2):379-87. PubMed ID: 18783810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach.
    Filone CM; Hodges EN; Honeyman B; Bushkin GG; Boyd K; Platt A; Ni F; Strom K; Hensley L; Snyder JK; Connor JH
    Chem Biol; 2013 Mar; 20(3):424-33. PubMed ID: 23521799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.
    Meier E; Harmison GG; Schubert M
    J Virol; 1987 Oct; 61(10):3133-42. PubMed ID: 3041035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA.
    Das T; Pattnaik AK; Takacs AM; Li T; Hwang LN; Banerjee AK
    Virology; 1997 Nov; 238(1):103-14. PubMed ID: 9375014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative domain-domain interactions in the vesicular stomatitis virus L polymerase protein appendage region.
    Ruedas JB; Perrault J
    J Virol; 2014 Dec; 88(24):14458-66. PubMed ID: 25297996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust kinetics of an RNA virus: Transcription rates are set by genome levels.
    Timm C; Gupta A; Yin J
    Biotechnol Bioeng; 2015 Aug; 112(8):1655-62. PubMed ID: 25726926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide small interfering RNA screen identifies host factors required for vesicular stomatitis virus infection.
    Lee AS; Burdeinick-Kerr R; Whelan SP
    J Virol; 2014 Aug; 88(15):8355-60. PubMed ID: 24829348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of vesicular stomatitis virus P and N proteins: identification of two overlapping domains at the N terminus of P that are involved in N0-P complex formation and encapsidation of viral genome RNA.
    Chen M; Ogino T; Banerjee AK
    J Virol; 2007 Dec; 81(24):13478-85. PubMed ID: 17913815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A temperature sensitive VSV identifies L protein residues that affect transcription but not replication.
    Galloway SE; Wertz GW
    Virology; 2009 Jun; 388(2):286-93. PubMed ID: 19395055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase Transitions Drive the Formation of Vesicular Stomatitis Virus Replication Compartments.
    Heinrich BS; Maliga Z; Stein DA; Hyman AA; Whelan SPJ
    mBio; 2018 Sep; 9(5):. PubMed ID: 30181255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal sequences of vesicular stomatitis virus RNA are both complementary and conserved.
    Keene JD; Schubert M; Lazzarini RA
    J Virol; 1979 Oct; 32(1):167-74. PubMed ID: 232169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of RNA by mutants of vesicular stomatitis virus (Indiana serotype) and the ability of wild-type VSV New Jersey to complement the VSV Indiana ts G I-114 transcription defect.
    Repik P; Flamand A; Bishop DH
    J Virol; 1976 Oct; 20(1):157-69. PubMed ID: 185410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-site mutations selected in transcriptional regulatory sequences compensate for engineered mutations in the vesicular stomatitis virus nucleocapsid protein.
    Harouaka D; Wertz GW
    J Virol; 2012 Oct; 86(20):11266-75. PubMed ID: 22875970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricted replication of vesicular stomatitis virus in T lymphocytes is coincident with a deficiency in a cellular protein kinase required for viral transcription.
    Sleat DE; Chikkala NF; Gautam S; Banerjee AK
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3125-32. PubMed ID: 1335023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesiculopolins, a New Class of Anti-Vesiculoviral Compounds, Inhibit Transcription Initiation of Vesiculoviruses.
    Ogino M; Fedorov Y; Adams DJ; Okada K; Ito N; Sugiyama M; Ogino T
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early steps of the virus replication cycle are inhibited in prostate cancer cells resistant to oncolytic vesicular stomatitis virus.
    Carey BL; Ahmed M; Puckett S; Lyles DS
    J Virol; 2008 Dec; 82(24):12104-15. PubMed ID: 18829743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.